1. Home
  2. CORT vs ONTO Comparison

CORT vs ONTO Comparison

Compare CORT & ONTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CORT
  • ONTO
  • Stock Information
  • Founded
  • CORT 1998
  • ONTO 1940
  • Country
  • CORT United States
  • ONTO United States
  • Employees
  • CORT N/A
  • ONTO N/A
  • Industry
  • CORT Biotechnology: Pharmaceutical Preparations
  • ONTO Industrial Machinery/Components
  • Sector
  • CORT Health Care
  • ONTO Industrials
  • Exchange
  • CORT Nasdaq
  • ONTO Nasdaq
  • Market Cap
  • CORT 8.1B
  • ONTO 6.1B
  • IPO Year
  • CORT N/A
  • ONTO N/A
  • Fundamental
  • Price
  • CORT $71.68
  • ONTO $92.70
  • Analyst Decision
  • CORT Strong Buy
  • ONTO Strong Buy
  • Analyst Count
  • CORT 4
  • ONTO 8
  • Target Price
  • CORT $142.00
  • ONTO $167.86
  • AVG Volume (30 Days)
  • CORT 1.4M
  • ONTO 2.1M
  • Earning Date
  • CORT 05-05-2025
  • ONTO 05-08-2025
  • Dividend Yield
  • CORT N/A
  • ONTO N/A
  • EPS Growth
  • CORT 8.36
  • ONTO 57.20
  • EPS
  • CORT 1.14
  • ONTO 4.42
  • Revenue
  • CORT $685,446,000.00
  • ONTO $1,025,082,000.00
  • Revenue This Year
  • CORT $35.85
  • ONTO $6.65
  • Revenue Next Year
  • CORT $35.22
  • ONTO $10.35
  • P/E Ratio
  • CORT $62.77
  • ONTO $21.00
  • Revenue Growth
  • CORT 30.93
  • ONTO 21.23
  • 52 Week Low
  • CORT $28.04
  • ONTO $85.88
  • 52 Week High
  • CORT $117.33
  • ONTO $238.93
  • Technical
  • Relative Strength Index (RSI)
  • CORT 46.01
  • ONTO 38.39
  • Support Level
  • CORT $74.34
  • ONTO $89.70
  • Resistance Level
  • CORT $80.65
  • ONTO $97.98
  • Average True Range (ATR)
  • CORT 3.81
  • ONTO 3.83
  • MACD
  • CORT -0.19
  • ONTO 0.02
  • Stochastic Oscillator
  • CORT 16.43
  • ONTO 20.59

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

About ONTO Onto Innovation Inc.

Onto Innovation Inc is engaged in the design, development, manufacture, and support of high-performance control metrology, defect inspection, lithography, and data analysis systems used by microelectronics device manufacturers. The Company and its subsidiaries currently operate in a single operating segment. The company mainly operates in the United States, Southeast Asia, China, Japan, and Europe, with Taiwan and South Korea the sources of total revenue.

Share on Social Networks: